Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 10 is a human protein encoded by the ZNF10 gene. It belongs to the C2H2-type zinc finger protein family and possesses a Kruppel-associated box (KRAB) domain, which is responsible for transcriptional repression. ZNF10 acts primarily as a transcriptional repressor, likely affecting gene expression via direct DNA binding. It interacts with proteins like TRIM28 and TIF1, which may mediate or enhance its repressive function. Currently, there are no known drugs targeting ZNF10, no evidence that it acts as a classical therapeutic target (such as a receptor or enzyme), and no prominent disease associations have been established for this protein[1][2][3][4][5][6][7][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 10 (ZNF10).